Xeris Biopharma’s Financial Pathway: Growth Amid Challenges (NASDAQ:XERS)


Business finance data analytics graph chart and smart digital marketing management concept, Businessman use the laptop to work marketing analysis chart strategic planning for sustainable development

NongAsimo

Introduction

Xeris Biopharma (NASDAQ:XERS), a biopharmaceutical firm, focuses on enhancing patient lives with innovative therapies. It offers products like Gvoke, Keveyis, and the FDA-approved Recorlev, while advancing further treatments using its unique XeriSol and XeriJect technologies.

The following



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *